agilon health (AGL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Executive summary
Tim O'Rourke appointed as Chief Executive Officer, President, and Class III Director, effective May 7, 2026, following an employment agreement signed April 24, 2026.
O'Rourke brings extensive healthcare leadership experience from Help at Home, Centene Corporation, Ascension Complete, and Humana.
Voting matters and shareholder proposals
No changes to the proposals to be acted on at the Annual Meeting; shareholders are not voting on O'Rourke's appointment.
Previously submitted proxies and voting instructions remain valid for the Annual Meeting.
Board of directors and corporate governance
O'Rourke appointed as a Class III Director with a term expiring at the 2027 annual meeting.
No family relationships or related party arrangements involving O'Rourke and current directors or executives.
Latest events from agilon health
- Profitability surged in Q1 2026, prompting raised full-year guidance and strong liquidity.AGL
Q1 20267 May 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with board support.AGL
Proxy filing23 Apr 2026 - Proxy covers director elections, auditor ratification, pay-for-performance, and ESG priorities.AGL
Proxy filing23 Apr 2026 - 2026 guidance targets breakeven EBITDA and $5.5B revenue after cost discipline and transformation.AGL
Q4 20257 Apr 2026 - Shareholders approved a reverse stock split and adjournment proposal, both backed by the Board.AGL
EGM 202617 Mar 2026 - Transformation, data-driven care, and disciplined contracting set the stage for growth and stability.AGL
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Disciplined contracting, cost controls, and clinical programs drive margin gains amid elevated trends.AGL
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - Stockholders to vote on a reverse stock split, reducing shares to as low as 16.6 million.AGL
Proxy Filing20 Feb 2026 - Virtual vote on reverse stock split and adjournment proposal to maintain NYSE compliance.AGL
Proxy Filing18 Feb 2026